Evaluation of Norovirus Component of a Gastrointestinal Diagnostic Assay Platform

To evaluate the norovirus component of the Vergene II gastrointestinal diagnostic assay platform.
Funding Partners:
  • Luminex Corporation
Program Partners:
  • CDC's National Center for Immunization and Respiratory Diseases
Program Location:
  • United States of America
Bacterial Diseases
Infectious Disease
Give
Infection Control